Japanese biopharmaceutical firm Anges Inc. said on Tuesday (local time) that it and partner Osaka University had completed development of a prophylactic DNA vaccine against the new coronavirus and that it would begin testing it in animals soon, Reuters reported.
There are now more than 350,000 cases of coronavirus infections globally and over 15,000 deaths.
Janglo
